Approaching "HIV elimination": Interventions for acute HIV infection

Current HIV/AIDS Reports

Volumn 3, Issue 4, 2006, Pages 160-168

  Pilcher, Christopher D ^a   Eaton, Lisa ^b   Kalichman, Seth ^b   Bisol, Cláudia ^b   Da Silva De Souza, Ricardo ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANTIBODY DETECTION; BRAZIL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; NUCLEIC ACID AMPLIFICATION; PATIENT COUNSELING; PREVENTIVE MEDICINE; PUBLIC HEALTH; REVIEW; RISK REDUCTION; VIRUS TRANSMISSION;

ACUTE DISEASE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; MASS SCREENING; PREVALENCE; PUBLIC HEALTH PRACTICE; RISK REDUCTION BEHAVIOR;

EID: 33750467974     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-006-0011-4     Document Type: Review

References (68)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS): UNAIDS 2004 report on the global AIDS epidemic. http://www.unaids.org/bangkok2004/report.html. Accessed March 16, 2005.
2. Smith DE, Walker BD, Cooper DA, et al.: Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS 2004, 18:709-718.
3. Pilcher CD, Eron JJ Jr, Galvin S, et al: Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest 2004, 113:937-945.
4. Schacker T, Collier AC, Hughes J, et al.: Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996, 125:257-264.
5. Bollinger RC, Brookmeyer RS, Mehendale SM, et al.: Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997, 278:2085-2089.
6. Pilcher CD, Price MA, Hoffman IF, et al.: Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004, 18:517-524.
7. Daar ES, Little S, Pitt J, et al.: Diagnosis of primary HIV-1 infection. Ann Intern Med 2001, 134:25-29.
8. Hecht FM, Busch MP, Rawal B, et al.: Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002, 16:1119-1129.
9. Pilcher CD, Eron JJ, Vernazza P, et al.: Sexual transmission during the incubation periods of primary HIV infection. J Am Med Assoc 2001, 268:1713-1714.
10. Borrow P, Lewicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997, 2:205-211.
11. Lindback S, Thorstensson R, Karlsson AC, et al.: Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000, 14:2333-2339.
12. Lindback S, Karlsson AC, Mittler J, et al.: Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS 2000, 14:2283-2291.
13. Pilcher CD, Tien HC, Eron JJ Jr, et al.: For the Duke-UNC-Emory Acute HIV Consortium. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004, 189:1785-1792.
14. Rosenberg ES, Caliendo AM, Walker BD: Acute HIV infection among patients tested for mononucleosis. N Engl J Med 1999, 340:969.
15. Pincus JM, Crosby SS, Losina E, et al.: Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin Infect Dis 2003, 37:1699-1704.
16. Weintrob AC, Giner J, Menezes P, et al.: Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Arch Intern Med 2003, 163:2097-2100.
17. Klausner JD, Grant RM, Kent CK: Detection of acute HIV infections. N Engl J Med 2005, 353:631-633.
18. Quinn TC, Brookmeyer R, Kline R, et al.: Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000, 14:2751-2757.
19. Pilcher CD, Fiscus SA, Nguyen TQ, et al.: Detection of acute HIV infections during HIV testing in North Carolina. New Engl J Med 2005, 152:1873-1883. This report details the experiences of the first public program to prove the concept of linking acute HIV intervention to lab-based AHI detection strategies.
20. Patel P, Klausner JD, Bacon OM, et al.: Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 2006, 42:75-79.
21. Priddy F, Pilcher CD, Moore R, et al.: NAAT-based screening for acute HIV infection in an urban HIV counseling and testing population in the Southeastern United States [abstract 964]. Program and Abstracts of the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 22-25, 2005.
22. Stekler J, Swenson PD, Wood RW, et al.: Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 2005, 19:1323-1325.
23. Stevens W, Akkers E, Scott L, et al.: High prevalence of undetected, acute HIV infection in a South African primary care clinic [abstract MoOa108]. Paper presented at the 3rd International AIDS Society Conference on HI V Pathogenesis and Treatment. Rio de Janeiro; July 24-27, 2005.
24. deSouza R, Pilcher CD, Fiscus SA, et al.: Rapid and efficient acute HIV detection by 4th generation Ag/Ab ELISA [abstract TUAB0201]. Paper presented at the XVI International AIDS Conference. Toronto; August 13-18, 2006.
25. Fiscus S, Pilcher CD, Miller W, et al.: Real-time detection of patients with acute HIV infection in Africa [abstract 20]. Program and Abstracts of the 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 22-25, 2005.
26. Daar ES, Moudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991, 324:961-964.
27. Vernazza PL, Eron JJ, Fiscus SA, Cohen MS: Sexual transmission of HIV: infectiousness and prevention. AIDS 1999, 13:155-166.
28. Quinn TC, Wawer MJ, Sewankambo N, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000, 342:921.
29. Gray RH, Wawer MJ, Brookmeyer R, et al.: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149-1153.
30. Stekler J, Sycks B, Holte S, et al.: Semen HIV dynamics and effect of ART following primary HIV infection [abstract 396]. Paper presented at the 13th Conference on Retroviruses and Opportunistic Infections. Denver: February 5-8, 2006.
31. Pullium JK, Adams DR, Jackson E, et al.: Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission. J Infect Dis 2001, 183:1023-1030.
32. Chakraborty H, Sen PK, Helms RW, et al.: Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001, 15:621-627.
33. Jacquez JA, Koopman JS, Simon CP, et al.: Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994, 7:1169-1184.
34. Koopman JS, Jacquez JA, Welch GW, et al.: The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:249-258.
35. Peterman TA, Stoneburner RL, Allen JR, et al.: Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 1988, 259:55-58.
36. Leynaert B, Downs AM, de Vincenzi I: Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. Am J Epidemiol 1998, 148:88-96.
37. Wawer MJ, Gray RH, Sewankambo NK, et al.: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005, 191:1403-1409. In this report of a secondary analysis of data from the Rakai study in Uganda, robust empirical estimates of the relationship between disease stage and individual infectiousness are provided. This article must serve as the cornerstone of any efforts to estimate program impact.
38. Cohen MS, Pilcher CD: Amplified transmission and new approaches to HIV prevention. J Infect Dis 2005, 191:1391-1393.
39. Wawer MJ, Gray RH, Sewankambo NK, et al.: A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998, 12:1211-1225.
40. Pilcher CD, Foust E, Ashby R, et al.: Sexual transmission risk and rapid public health intervention in acute HIV infection [abstract 371]. Program and Abstracts of the 13th Conference on Retroviruses and Opportunistic Infections. Denver, February 5-8, 2006.
41. Centers for Disease Control and Prevention: Report of the Syphilis Elimination Consultation, 1-2 August 2005. Atlanta. October 2005. Available at http://www.cdc. gov/stopsyphilis/SyphElimConsultationMeeting.pdf.
42. Patterson KB, Leone PA, Fiscus SA, et al.: Detection of acute HIV infection in pregnant women in North Carolina [abstract 370]. Program and Abstracts of the 13th Conference on Retroviruses and Opportunistic Infections. Denver; February 5-8, 2006.
43. Kalichman SC, DiFonzo K, Kyomugsha F, et al.: When briefer can be better: single session approaches to HIV risk reduction interventions. Interam J Psychol 2001, 35:41-58.
44. Kamb M, Fishbein M, Douglas J, et al.: Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. JAMA 1998, 280:1161-1167.
45. Metcalf C, Douglas J, Malotte CK, et al.: Relative efficacy of prevention counseling with rapid HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis 2005, 32:130-138.
46. Weinhardt LS, Carey MP, Johnson BT, Bickham NL: Effects of HIV counseling and testing on sexual risk behavior: meta-analysis of published research, 1985-1997. Am J Public Health 1999, 89:1397-1405.
47. Weinhardt LS: HIV diagnosis and risk behavior. In Positive Prevention: Sourcebook for HIV Risk Reduction with People Living with HIV/AIDS. Edited by Kalichman SC. Springer/Kluwer; 2005.
48. Belcher L, Kalichman SC, Topping M, et al.: Randomized trial of a brief HIV risk reduction counseling intervention for women. J Consult Clin Psychol 1998, 66:856-861.
49. Kalichman SC, Weinhardt LS, Benotsch E, et al.: Experimental components analysis of brief theory-based HIV-AIDS risk reduction counseling for sexually transmitted infection patients. Health Psychol 2005, 24:198-208.
50. Simbayi LC, Kalichman SC, Skinner D, et al.: Theory-based HIV risk reduction counseling for sexually transmitted infection clinic patients in Cape Town, South Africa. Sex Transmit Dis 2004, 31:727-733.
51. Khalsa AM: Preventive counseling, screening, and therapy for the patient with newly diagnosed HIV infection. Am Fam Physician 2006, 73:271-280.
52. Centers for Disease Control and Prevention: A glance at the HIV/AIDS epidemic, http://www.cdc.gov/hiv/resources/factsheets/At-A-Glance.htm. Accessed May 10, 2006.
53. National Institute of Allergy and Infectious Diseases: HIV infection and AIDS: An overview. http://www.niaid.nih. gov/factsheets/hivinf.htm. Accessed May 10, 2006.
54. Golub SA, Indyk D: HIV-infected individuals as partners in prevention: A redefinition of the partner notification process. Soc Work Health Care 2006, 42:225-235.
55. de Souza L, Munday PE: Audit of HIV partner notification in a district general hospital. Int J STD AIDS 2003, 14:854-855.
56. Passin WF, Kim AS, Hutchinson AB, et al.: A systematic review of the HIV partner counseling and referral services: Client and provider attitudes, preferences, practices, and experiences. Sex Transm Dis 2006, 33:320-328. An excellent and exhaustive review of "PCRS" in HIV infection.
57. Foust E, Leone P, Vanhoy T, et al.: Partner counseling and referral services to identify persons with undiagnosed HIV-North Carolina, 2001. Mor Mortal Wkly Rep 2003, 52:1181-1184.
58. Golden MR, Hogben M, Potterat JJ, Handsfield HH: HIV partner notification in the United States. A national survey of program coverage and outcomes. Sex Transm Dis 2004, 31:709-712.
59. Melchior R: HIV/AIDS NO BRASIL Análise de 322 serviços em 7 estados brasileiros (CE, MA, MS, PA, RJ, RS, SP). Tese de Doutorado. Universidade de São Paulo; 2003.
60. Okie S: Fighting HIV-lessons learned from Brazil. N Engl J Med 2006, 354:1977-1981.
61. Paiva V, Pupo LR, Barboza R: The right to prevention and the challenges of reducing vulnerability to HIV in Brazil. Revista de Saúde Pública 2006, 40:109-119.
62. Brazil Launches Free HIV Testing Campaign [press release]. Menlo Park, CA: Henry J. Kaiser Family Foundation; November 3, 2003. http://www. kaisernetwork.org/daily_ reports/rep_index.cfm?hint=1&DR_ID=20647. Accessed April 4, 2005,
63. Levi GC, Vitória MA. Fighting against AIDS: the Brazilian experience. AIDS 2002, 16:2373-2383.
64. Soares EA, Martinez AM, Souza TM, et al.: HIV-1 subtype C dissemination in southern Brazil. AIDS 2005, 19(Suppl 4):S81-S86.
65. Ferreira MPS, Silva C, Gomes MCF, Silva SMB: Testagem sorológica para o HIV e a importância dos Centros de Testagem e Aconselhamento (CTA)-resultados de uma pesquisa no município do Rio de Janeiro. Ciência Saúde Coletiva 2001, 6:481-490.
66. Ferreir, OC Jr, Ferreira C, Riedel M, et al.: For the HIV Rapid Test Study Group - evaluation of rapid tests for anti-HIV detection in Brazil. AIDS 2005, 19(Suppl 4):S70-S75.
67. Araújo MA, Bucher JSNF, Bello PY: Eficácia do aconselhamento para doenças sexualmente transmissíveis em unidades de Referência da cidade de Fortaleza, CE, Brasil. DST - Journal Brasileiro de Doenças Sexualmente Transmissíveis 2004, 16:31-37.
68. Fiebig EW, Wright DJ, Rawal BD, et al.: Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879. The results of exhaustive testing of "seroconversion panels" (serial samples obtained from seroconverting blood and serum donors) are presented using a wide array of commercially available tests. Although many may take issue with some of the paper's results, it provides unique and useful data on the utility of specific types of HIV testing at different disease stages.